Publicaciones (140) Publicaciones de ÓSCAR PALOMARES GRACIA

2024

  1. The Role of Regulatory T Cells in Allergic Diseases: Collegium Internationale Allergologicum (CIA) Update 2024

    International Archives of Allergy and Immunology

2023

  1. A tumor-associated heparan sulfate-related glycosaminoglycan promotes the generation of functional regulatory T cells

    Cellular and Molecular Immunology, Vol. 20, Núm. 12, pp. 1499-1512

  2. C-Type Lectin Receptor Mediated Modulation of T2 Immune Responses to Allergens

    Current Allergy and Asthma Reports, Vol. 23, Núm. 3, pp. 141-151

  3. Cannabinoid WIN55,212-2 reprograms monocytes and macrophages to inhibit LPS-induced inflammation

    Frontiers in Immunology, Vol. 14

  4. Could we co-opt the cannabinoid system for asthma therapy?

    Expert Review of Clinical Immunology

  5. From trained immunity in allergy to trained immunity-based allergen vaccines

    Clinical and Experimental Allergy, Vol. 53, Núm. 2, pp. 145-155

  6. Ligelizumab impairs IgE-binding to plasmacytoid dendritic cells more potently than omalizumab and restores IFN-α production and FOXP3+ Treg generation

    Allergy: European Journal of Allergy and Clinical Immunology, Vol. 78, Núm. 4, pp. 1060-1072

  7. Metabolic pathways in immune senescence and inflammaging: Novel therapeutic strategy for chronic inflammatory lung diseases. An EAACI position paper from the Task Force for Immunopharmacology

    Allergy: European Journal of Allergy and Clinical Immunology

  8. Nomenclature of allergic diseases and hypersensitivity reactions: Adapted to modern needs: An EAACI position paper

    Allergy: European Journal of Allergy and Clinical Immunology, Vol. 78, Núm. 11, pp. 2851-2874

  9. Rhinitis associated with asthma is distinct from rhinitis alone: The ARIA-MeDALL hypothesis

    Allergy: European Journal of Allergy and Clinical Immunology, Vol. 78, Núm. 5, pp. 1169-1203

  10. Tonsillar transcriptional profiles in atopic and non-atopic subjects

    Allergy: European Journal of Allergy and Clinical Immunology, Vol. 78, Núm. 2, pp. 522-536

  11. Transcriptional analysis of nasal polyps fibroblasts reveals a new source of pro-inflammatory signaling in CRSwNP*

    Rhinology, Vol. 61, Núm. 2, pp. 180-189

  12. Type 2 chronic inflammatory diseases: targets, therapies and unmet needs

    Nature Reviews Drug Discovery, Vol. 22, Núm. 9, pp. 743-767

2022

  1. Allergoid-mannan conjugates imprint tolerogenic features in human macrophages

    Allergy: European Journal of Allergy and Clinical Immunology

  2. Allergoid–mannan conjugates reprogram monocytes into tolerogenic dendritic cells via epigenetic and metabolic rewiring

    Journal of Allergy and Clinical Immunology, Vol. 149, Núm. 1, pp. 212-222.e9

  3. COVID-19 vaccination in patients receiving allergen immunotherapy (AIT) or biologicals—EAACI recommendations

    Allergy: European Journal of Allergy and Clinical Immunology, Vol. 77, Núm. 8, pp. 2313-2336

  4. Candida albicans V132 induces trained immunity and enhances the responses triggered by the polybacterial vaccine MV140 for genitourinary tract infections

    Frontiers in Immunology, Vol. 13

  5. Cannabinoid WIN55212-2 impairs peanut-allergic sensitization and promotes the generation of allergen-specific regulatory T cells

    Clinical and Experimental Allergy, Vol. 52, Núm. 4, pp. 540-549

  6. Cannabinoids induce functional Tregs by promoting tolerogenic DCs via autophagy and metabolic reprograming

    Mucosal Immunology, Vol. 15, Núm. 1, pp. 96-108

  7. EAACI Biologicals Guidelines—Omalizumab for the treatment of chronic spontaneous urticaria in adults and in the paediatric population 12–17 years old

    Allergy: European Journal of Allergy and Clinical Immunology, Vol. 77, Núm. 1, pp. 17-38